Erste Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$80.1M Sell
2,704,900
-100,000
-4% -$2.84M 0.74% 30
2025
Q4
$76.3M Buy
2,804,900
+40,000
+1% +$1.4M 0.64% 36
2025
Q3
$109M Buy
2,764,900
+438,411
+19% +$16.5M 1.05% 18
2025
Q2
$77.4M Buy
2,326,489
+96,589
+4% +$2.93M 0.65% 31
2025
Q1
$65.4M Buy
2,229,900
+220,000
+11% +$7.3M 0.84% 30
2024
Q4
$66.4M Sell
2,009,900
-175,000
-8% -$8.22M 0.81% 28
2024
Q3
$97.2M Sell
2,184,900
-70,000
-3% -$3.18M 1.16% 12
2024
Q2
$97.3M Sell
2,254,900
-25,000
-1% -$902K 1.29% 11
2024
Q1
$66.7M Buy
2,279,900
+172,000
+8% +$4.61M 0.91% 23
2023
Q4
$47M Buy
2,107,900
+413,700
+24% +$9.27M 0.69% 41
2023
Q3
$41.9M Hold
1,694,200
0.72% 37
2023
Q2
$47.9M Hold
1,694,200
0.85% 26
2023
Q1
$38.9M Hold
1,694,200
0.74% 38
2022
Q4
$47.5M Hold
1,694,200
1% 18
2022
Q3
$47.9M Sell
1,694,200
-35,000
-2% -$939K 1.07% 14
2022
Q2
$38.3M Buy
1,729,200
+100,000
+6% +$2.26M 0.85% 29
2022
Q1
$47.4M Buy
1,629,200
+51,000
+3% +$1.56M 0.91% 24
2021
Q4
$53M Buy
1,578,200
+435,000
+38% +$17.5M 0.95% 19
2021
Q3
$52.8M Buy
1,143,200
+59,300
+5% +$2.86M 1.04% 13
2021
Q2
$59.6M Buy
1,083,900
+30,000
+3% +$1.68M 1.19% 12
2021
Q1
$54.3M Hold
1,053,900
1.33% 9
2020
Q4
$46.9M Buy
1,053,900
+66,400
+7% +$2.63M 1.3% 10
2020
Q3
$34.5M Buy
987,500
+77,400
+9% +$3.39M 1.18% 13
2020
Q2
$48.6M Sell
910,100
-125,300
-12% -$5.8M 1.94% 4
2020
Q1
$36.7M Sell
1,035,400
-43,300
-4% -$2M 2.14% 3
2019
Q4
$51.8M Buy
1,078,700
+268,000
+33% +$10.1M 2.29% 5
2019
Q3
$26.4M Buy
810,700
+116,000
+17% +$4.8M 1.41% 17
2019
Q2
$34.6M Buy
694,700
+120,000
+21% +$6.41M 1.84% 7
2019
Q1
$38.6M Buy
574,700
+15,100
+3% +$880K 2.16% 5
2018
Q4
$25.3M Buy
+559,600
New +$34.5M 1.7% 10

Other funds holding AGIO